Single-nucleus RNA-seq identifies divergent populations of FSHD2 myotube nuclei
0301 basic medicine
570
Facioscapulohumeral
Intellectual and Developmental Disabilities (IDD)
Facioscapulohumeral Muscular Dystrophy
Cells
Muscle Fibers, Skeletal
Bioinformatics and Computational Biology
QH426-470
Muscle Fibers
Myoblasts
03 medical and health sciences
Rare Diseases
Exome Sequencing
Genetics
2.1 Biological and endogenous factors
Humans
Muscular Dystrophy
RNA-Seq
Stem Cell Research - Embryonic - Human
Aetiology
Cells, Cultured
Cell Nucleus
Cultured
Microfilament Proteins
Nuclear Proteins
RNA-Binding Proteins
Cell Differentiation
Skeletal
Biological Sciences
Stem Cell Research
Muscular Dystrophy, Facioscapulohumeral
Brain Disorders
HEK293 Cells
Gene Expression Regulation
Case-Control Studies
Single-Cell Analysis
Biotechnology
Developmental Biology
Research Article
DOI:
10.1371/journal.pgen.1008754
Publication Date:
2020-05-04T17:40:09Z
AUTHORS (9)
ABSTRACT
FSHD is characterized by the misexpression of DUX4 in skeletal muscle. Although DUX4 upregulation is thought to be the pathogenic cause of FSHD, DUX4 is lowly expressed in patient samples, and analysis of the consequences of DUX4 expression has largely relied on artificial overexpression. To better understand the native expression profile of DUX4 and its targets, we performed bulk RNA-seq on a 6-day differentiation time-course in primary FSHD2 patient myoblasts. We identify a set of 54 genes upregulated in FSHD2 cells, termed FSHD-induced genes. Using single-cell and single-nucleus RNA-seq on myoblasts and differentiated myotubes, respectively, we captured, for the first time, DUX4 expressed at the single-nucleus level in a native state. We identified two populations of FSHD myotube nuclei based on low or high enrichment of DUX4 and FSHD-induced genes ("FSHD-Lo" and "FSHD Hi", respectively). FSHD-Hi myotube nuclei coexpress multiple DUX4 target genes including DUXA, LEUTX and ZSCAN4, and also upregulate cell cycle-related genes with significant enrichment of E2F target genes and p53 signaling activation. We found more FSHD-Hi nuclei than DUX4-positive nuclei, and confirmed with in situ RNA/protein detection that DUX4 transcribed in only one or two nuclei is sufficient for DUX4 protein to activate target genes across multiple nuclei within the same myotube. DUXA (the DUX4 paralog) is more widely expressed than DUX4, and depletion of DUXA suppressed the expression of LEUTX and ZSCAN4 in late, but not early, differentiation. The results suggest that the DUXA can take over the role of DUX4 to maintain target gene expression. These results provide a possible explanation as to why it is easier to detect DUX4 target genes than DUX4 itself in patient cells and raise the possibility of a self-sustaining network of gene dysregulation triggered by the limited DUX4 expression.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (53)
CITATIONS (38)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....